COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,389 Articles (22,816 medRxiv, 8,573 bioRxiv)

Most recent first Previous |  Page 365: Articles 3641-3650  | Next

Ensitrelvir Fumaric Acid in Patients with SARS-CoV-2: A Retrospective Chart Review
Yamato, M., Kinoshita, M., Miyazawa, S., Seki, M., Mizuno, T., Sonoyama, T.
10.1101/2023.09.03.23294865 — Posted: 2023-09-03
Pulmonary function and survival one year after dupilumab treatment of acute moderate to severe COVID-19: A follow up study from a Phase IIa trial
Hendrick, J., Ma, J. Z., Haughey, H. M., Coleman, R., Nayak, U., Kadl, A., Sturek, J. M., Jackson, P., Young, M. K., Allen, J. E., Petri, W. A.
10.1101/2023.09.01.23293947 — Posted: 2023-09-02
A mathematical model for multiple COVID-19 waves applied to Kenya
Ogana, W., Juma, V. O., Bulimo, W. D., Chiteri, V. N.
10.1101/2023.09.01.23294943 — Posted: 2023-09-02
COVID-19-related school closures, United States, July 27, 2020 - June 30, 2022
Zviedrite, N., Jahan, F. A., Moreland, S., Ahmed, F., Uzicanin, A.
10.1101/2023.08.31.23294738 — Posted: 2023-09-02
Application of MALDI-MS and Machine Learning to Detection of SARS-CoV-2 and non-SARS-CoV-2 Respiratory Infections.
Yegorov, S., Kadyrova, I., Korshukov, I., Sultanbekova, A., Barkhanskaya, V., Bashirova, T., Zhunusov, Y., Li, Y., Parakhina, V., Kolesnichenko, S., Baiken, Y., Matkarimov, B., Vazenmiller, D., Miller, M. S., Hortelano, G. H., Turmuhambetova, A., Chesca, A. E., Babenko, D.
10.1101/2023.08.31.23294891 — Posted: 2023-09-02
A response playbook for early detection and population surveillance of new SARS-CoV-2 variants in a regional public health laboratory
Barbian, H. J., Kittner, A., Teran, R., Bobrovska, S., Qiu, X., English, K., Green, S. J., Ghinai, I., Pacilli, M., Hayden, M. K.
10.1101/2023.09.01.23293209 — Posted: 2023-09-02
How will COVID-19 persist in the future? Simulating future dynamics of COVID-19 using an agent-based network model
Roubenoff, E.
10.1101/2023.08.29.23294791 — Posted: 2023-09-01
Can long-term COVID-19 vaccination be improved by serological surveillance?: a modeling study for Mozambique
Liu, C. Y., Shioda, K., Kraay, A., Massora, S., de Jesus, A., Massinga, A., Monjane, C., Omer, S. B., Jenness, S. M., Nelson, K., Flasche, S. Y., Mandomando, I., Lopman, B. A.
10.1101/2023.08.29.23294793 — Posted: 2023-09-01
Symptom experience before vs. after confirmed SARS-CoV-2 infection: a population and case control study using prospectively recorded symptom data.
Sudre, C. H., Antonelli, M., Cheetham, N. J., Molteni, E., Canas, L. S., Bowyer, V., Murray, B., Rjoob, K., Modat, M., Capdevia Pujol, J., Hu, C., Wolf, J., Spector, T. D., Hammers, A., Steves, C. J., Ourselin, S., Duncan, E. L.
10.1101/2023.08.30.23294821 — Posted: 2023-09-01
Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated Beta-2-Adrenergic Receptor Autoantibodies
Stein, E., Heindrich, C., Wittke, K., Kedor, C., Kim, L., Freitag, H., Krueger, A., Toelle, M., Scheibenbogen, C.
10.1101/2023.08.31.23294813 — Posted: 2023-09-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).